Biomarkers Market Valuation Expected to Cross $93.8 Billion by 2029 The biomarkers market, with an estimated worth of $57.7 billion in 2024, is expected to increase to $93.8 billion by 2029, growing at a CAGR of 10.2%. The study provides a detailed analysis of industry trends, pricing structures, patent evaluations, insights from conferences, stakeholder identification, and market purchasing dynamics.
Download PDF brochure
DRIVER: Increase in global...
0 Shares
62 Views
0 Reviews